Medicine and Dentistry
Atherosclerosis
8%
Awareness
5%
Biological Marker
16%
Blood Pressure
14%
Breathing
8%
C-Peptide
8%
Cardiovascular Disease
18%
Cardiovascular Mortality
8%
Cardiovascular Risk
8%
Cardiovascular System
6%
Case-Control Study
11%
Cohort Analysis
22%
Diabetes
58%
Diabetes Mellitus
31%
Diabetic Ketoacidosis
9%
Disease
5%
Drug Therapy
8%
Fibroblast Growth Factor 23
8%
Flushing
33%
Glycemic
17%
Glycemic Control
18%
Glycon
10%
Hazard Ratio
10%
Health Care Cost
12%
Hemoglobin A1c
48%
Hyperglycemia
9%
Hypoglycemia
11%
Insulin Dependent Diabetes Mellitus
100%
Insulin Infusion
28%
Insulin Treatment
24%
Kidney Graft
11%
Leg Amputation
8%
Lipoprotein
6%
Maturity Onset Diabetes of the Young
75%
Microvascular Complication
18%
Nephropathy
7%
Observational Study
8%
Outpatient
9%
Patient with Diabetes
6%
Patient with Type 1 Diabetes
10%
Patient with Type 2 Diabetes
32%
Phenotype
8%
Primary Health Care
10%
Proportional Hazards Model
6%
Prospective Cohort Study
15%
Prospective Study
13%
Quality of Life
20%
Secretion (Process)
6%
Thiol
8%
Type 2 Diabetes
7%
Keyphrases
Albuminuria
9%
All-cause Mortality
29%
Cardiovascular Disease
12%
Cardiovascular Mortality
21%
Carnosinase
12%
Confidence Interval
9%
Continuous Glucose Monitoring
18%
Continuous Subcutaneous Insulin Infusion
9%
Diabetes
27%
Diabetic Ketoacidosis
8%
DUD-E
8%
Dutch
10%
Fibroblast Growth Factor 23 (FGF23)
16%
Flash Glucose Monitoring
12%
FreeStyle Libre
11%
Gasotransmitter
8%
Glycemic Control
13%
Hazard Ratio
8%
Hemoglobin A1c (HbA1c)
25%
Idiopathic Membranous Nephropathy
8%
Incident Diabetes
8%
Insulin
8%
Insulin Administration
13%
Insulin Resistance
8%
Insulin Therapy
8%
Insulin-like Growth factor-1
8%
Kidney Transplant Recipients
11%
Long-term Mortality
8%
Low-density Lipoprotein
8%
Lower Limb Amputation
8%
Meta-analysis
8%
Metformin
13%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
10%
Netherlands
25%
Patients with Diabetes
22%
Post-transplant Diabetes Mellitus
8%
Prospective Cohort Study
11%
Redox Status
12%
Serum Calcification Propensity
16%
Serum Carnosinase
12%
Subclinical Atherosclerosis
8%
T 50
8%
Trimethylamine N-oxide
8%
Type 1 Diabetes Mellitus (T1DM)
77%
Type 2 Diabetes Mellitus (T2DM)
78%
Type 2 Diabetic Patients
34%
Type I Diabetes
35%
Vascular Complications
15%
Zodiac
12%
Zwolle
22%
Pharmacology, Toxicology and Pharmaceutical Science
Albuminuria
6%
All Cause Mortality
21%
Biological Marker
10%
Cardiovascular Disease
24%
Cardiovascular Mortality
20%
Cardiovascular Risk
9%
Case-Control Study
5%
Cohort Study
24%
Cyclophosphamide
5%
Diabetes Mellitus
19%
Diabetic Ketoacidosis
9%
Diabetic Nephropathy
14%
Disease
12%
Fibroblast Growth Factor 23
12%
Gasotransmitter
8%
Hemoglobin A1c
44%
Hypoglycemia
7%
Insulin Dependent Diabetes Mellitus
88%
Insulin Resistance
8%
Kidney Disease
8%
Lipoprotein
8%
Membranous Glomerulonephritis
8%
Metformin
10%
Mixed Model
6%
Non Insulin Dependent Diabetes Mellitus
75%
Observational Study
9%
Prevalence
9%
Prospective Cohort Study
8%
Prospective Study
9%
Replacement Therapy
6%
Somatomedin C
5%
Thiol
12%
Triacylglycerol
10%
Trimethylamine
8%
